Easton Pharmaceuticals Announces It Has Received $400,000 USD In Product Purchase Orders For The Current Quarter

TORONTO, ON–(Marketwired – Jun 26, 2017) – Easton Pharmaceuticals, Inc. (OTC: EAPH), is pleased to announce it has received an approximate total of $400,000 USD in purchase orders for the quarter from its sub-distributors for the Mexican market. The purchase orders include a new order received just last week,…

Easton Pharmaceuticals Announces It Has Finalized Agreement Terms With Alliance Group For Ownership Stake in Several Businesses On 45 Acres Of Agricultural Land, Which Includes The Cultivation of Medical Marijuana For National Canadian Market

Cash Investment Terms Include Guaranteed Revenues Secured With Collateralized Mortgage On Property, Revenues To Commence Within 60 Days TORONTO, ON–(Marketwired – Jun 12, 2017) – Easton Pharmaceuticals, Inc. (OTC PINK: EAPH), is pleased to announce, pursuant to its previously announced Letter of Intent with Canadian based — Alliance Group…

Legalization of Medical Marijuana in Mexico Creates Opportunities For EAPH

Mexico Approves Medical Marijuana Mexico’s Lower House of Congress recently passed a bill that legalizes the use of medical marijuana and scientific research. In particular, the bill classifies the controversial psychoactive component of marijuana — tetrahydrocannabinol or THC — as “therapeutic”. The move is akin to the U.S. Drug…

Easton Pharmaceuticals Inc (OTCMKTS:EAPH) Finalizes Acquisition Deal – May Highlights

Easton Pharmaceuticals Inc (OTCMKTS:EAPH) has finalized a LOI for the purchase of revenue producing therapeutics firm, Herbs of Kedem. The company has sales in surplus of $2.2 million and healthy profit margins with an existing net profit of almost $1.5 million with minimal marketing coverage. The highlights Herbs of…

Easton Pharmaceuticals Announces Formally Accepting Proposal For The Sub-Licensing Of Product VS-Sense From German based Multi-National Pharmaceutical Company For Mexico; Agreement Includes An Up-Front Cash Payment And a Recurring Royalty

TORONTO, ON–(Marketwired – May 15, 2017) – Easton Pharmaceuticals, Inc. (OTC PINK: EAPH), announces that Easton / BMV Medica have formally accepted a proposal for the sub-licensing of product VS-Sense from a German based multi-national pharmaceutical company for Mexico, which includes an upfront cash payment to Easton / BMV…

Easton Pharmaceuticals Announces Signing Of Purchase Agreement Completing The Acquisition Of Revenue Producing Vaporizer and e-Liquids Manufacturer iBliss, Inc.

TORONTO, ON–(Marketwired – Apr 20, 2017) – Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) is pleased to announce the execution of final agreement completing the 100% acquisition of revenue generating vaporizer and e-liquids manufacturer, iBliss Inc. and its holding company. Easton Pharmaceuticals and iBliss, Inc. executed the closing final agreement,…